Product Profile of Anti-Cancer Doxorubicin Hydrochloride For Injection

Serum Institute of India Ltd manufactures Anti- Cancer Doxorubicin Hydrochloride for Injection. Serum Institute of India Ltd, a group company of Poonawalla Group also manufactures Tetanus Anti-toxin and Anti-snake Venom serum, DTP [Diphtheria, Tetanus and Pertussis] group of Vaccines and MMR [Measles, Mumps and Rubella] group of vaccines. The Anti- Cancer Doxorubicin Hydrochloride for Injection is used for cancer treatment.

The Composition of Anti- Cancer Doxorubicin Hydrochloride for Injection is as follows:

• Each vial of 10mg contains 10 mg Doxorubicin Hydrochloride and Lactose

• Each vial of 50 mg contains 50mg Doxorubicin Hydrochloride and Lactose